Genetic Variants in the Wnt Signaling Pathway Are Not Associated with Survival Outcome of Non-Small Cell Lung Cancer in a Korean Population.
Seung Soo YooMi Jeong HongJin Eun ChoiJang Hyuck LeeSun Ah BaekWon Kee LeeSo Yeon LeeShin-Yup LeeJaehee LeeSeung-Ick ChaChang Ho KimSukki ChoJae Yong ParkPublished in: Journal of Korean medical science (2016)
Recently, genetic variants in the WNT signaling pathway have been reported to affect the survival outcome of Caucasian patients with early stage non-small cell lung cancer (NSCLC). We therefore attempted to determine whether these same WNT signaling pathway gene variants had similar impacts on the survival outcome of NSCLC patients in a Korean population. A total of 761 patients with stages I-IIIA NSCLC were enrolled in this study. Eight variants of WNT pathway genes were genotyped and their association with overall survival and disease-free survival were analyzed. None of the eight variants were significantly associated with overall survival or disease-free survival. There were no differences in survival outcome after stratifying the subjects according to age, gender, smoking status, and histological type. These results suggest that genetic variants in the WNT signaling pathway may not affect the survival outcome of NSCLC in a Korean population.
Keyphrases
- free survival
- signaling pathway
- small cell lung cancer
- stem cells
- cell proliferation
- early stage
- pi k akt
- copy number
- end stage renal disease
- genome wide
- induced apoptosis
- mental health
- chronic kidney disease
- newly diagnosed
- oxidative stress
- ejection fraction
- prognostic factors
- dna methylation
- epidermal growth factor receptor
- lymph node
- brain metastases
- patient reported outcomes
- smoking cessation
- peritoneal dialysis